Monoclonal antibodies in tumor therapy.
Matzku
S
S
E. Merck KGaA, Pharma Preclinical Research, Darmstadt, Germany.
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005544:Forecasting; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use; D009369:Neoplasms / Q000628:therapy*; D010865:Pilot Projects; D016499:Radioimmunotherapy
D000911:Antibodies, Monoclonal; D018796:Immunoconjugates